品牌:NIBSC
发货:30天内
信息标签:NIBSC WHO标准品,供应,化工,化学试剂
01/532 |
Meningococcal serogroup W polysaccharide |
13/164 |
Influenza Antigen B/Massachusetts/02/2042 (Egg derived) |
13/144 |
Influenza Antigen B/Massachusetts/02/2022 (Egg derived) |
10/147 |
Reteplase Reference Material |
10/206 |
Reteplase Reference Material |
07/289 |
BCG Vaccine of Russian BCG-I sub-strain(16st WHO Reference Reagent) |
95/613 |
Interleukin-74 (Human, rDNA derived) |
10/123 |
Reteplase Reference Material |
12/B623-046 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC44 |
13/166 |
Influenza Antigen B/Massachusetts/02/2044 (Egg derived) |
13/172 |
C-Peptide, Human. 27st International Standard. |
95/573 |
Interleukin-34 (Human, rDNA derived) |
13/293 |
Polio Anti Sabin type 76 (inactivated) Serum |
95/591 |
Interleukin-52 (Human, rDNA derived) |
10/129 |
Reteplase Reference Material |
95/659 |
Interleukin-120 (Human, rDNA derived) |
12/B623-055 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC53 |
07/375 |
BCG Vaccine of Russian BCG-I sub-strain(102st WHO Reference Reagent) |
07/330 |
BCG Vaccine of Russian BCG-I sub-strain(57st WHO Reference Reagent) |
12/B623-007 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC5 |
03/104-019 |
HTLV-4 (antibody) Monitor Sample |
95/581 |
Interleukin-42 (Human, rDNA derived) |
07/346 |
BCG Vaccine of Russian BCG-I sub-strain(73st WHO Reference Reagent) |
03/104-120 |
HTLV-105 (antibody) Monitor Sample |
01/451 |
Meningococcal serogroup W polysaccharide |
01/428 |
Meningococcal serogroup W polysaccharide |
95/610 |
Interleukin-71 (Human, rDNA derived) |
07/331 |
BCG Vaccine of Russian BCG-I sub-strain(58st WHO Reference Reagent) |
12/B623-109 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC107 |
12/B623-086 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
12/B623-108 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC106 |
12/B623-022 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC20 |
13/178 |
Influenza Antigen B/Massachusetts/02/2056 (Egg derived) |
12/B623-063 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC61 |
07/372 |
BCG Vaccine of Russian BCG-I sub-strain(99st WHO Reference Reagent) |
01/480 |
Meningococcal serogroup W polysaccharide |
07/361 |
BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent) |
01/465 |
Meningococcal serogroup W polysaccharide |
10/143 |
Reteplase Reference Material |
95/601 |
Interleukin-62 (Human, rDNA derived) |
03/104-031 |
HTLV-16 (antibody) Monitor Sample |
12/B623-058 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC56 |
13/225 |
C-Peptide, Human. 80st International Standard. |
12/B623-097 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
10/159 |
Reteplase Reference Material |
01/492 |
Meningococcal serogroup W polysaccharide |
07/357 |
BCG Vaccine of Russian BCG-I sub-strain(84st WHO Reference Reagent) |
03/104-079 |
HTLV-64 (antibody) Monitor Sample |
07/351 |
BCG Vaccine of Russian BCG-I sub-strain(78st WHO Reference Reagent) |
13/199 |
C-Peptide, Human. 54st International Standard. |
95/557 |
Interleukin-18 (Human, rDNA derived) |
01/439 |
Meningococcal serogroup W polysaccharide |
13/240 |
Polio Anti Sabin type 23 (inactivated) Serum |
10/148 |
Reteplase Reference Material |
01/526 |
Meningococcal serogroup W polysaccharide |
12/B623-096 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC94 |
03/104-023 |
HTLV-8 (antibody) Monitor Sample |
13/224 |
C-Peptide, Human. 79st International Standard. |
07/274 |
BCG Vaccine of Russian BCG-I sub-strain(1st WHO Reference Reagent) |
13/316 |
Polio Anti Sabin type 99 (inactivated) Serum |
13/221 |
C-Peptide, Human. 76st International Standard. |
95/641 |
Interleukin-102 (Human, rDNA derived) |
12/B623-048 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC46 |
13/192 |
Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
13/198 |
C-Peptide, Human. 53st International Standard. |
01/497 |
Meningococcal serogroup W polysaccharide |
95/655 |
Interleukin-116 (Human, rDNA derived) |
13/176 |
Influenza Antigen B/Massachusetts/02/2054 (Egg derived) |
13/186 |
Influenza Antigen B/Massachusetts/02/2064 (Egg derived) |
13/174 |
Influenza Antigen B/Massachusetts/02/2052 (Egg derived) |
95/635 |
Interleukin-96 (Human, rDNA derived) |
95/639 |
Interleukin-100 (Human, rDNA derived) |
95/622 |
Interleukin-83 (Human, rDNA derived) |
13/311 |
Polio Anti Sabin type 94 (inactivated) Serum |
10/124 |
Reteplase Reference Material |
10/163 |
Reteplase Reference Material |
10/105 |
Reteplase Reference Material |
01/484 |
Meningococcal serogroup W polysaccharide |
01/454 |
Meningococcal serogroup W polysaccharide |
07/359 |
BCG Vaccine of Russian BCG-I sub-strain(86st WHO Reference Reagent) |
01/457 |
Meningococcal serogroup W polysaccharide |
10/182 |
Reteplase Reference Material |
13/137 |
Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
13/205 |
Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
01/467 |
Meningococcal serogroup W polysaccharide |
03/104-018 |
HTLV-3 (antibody) Monitor Sample |
13/275 |
Polio Anti Sabin type 58 (inactivated) Serum |
95/586 |
Interleukin-47 (Human, rDNA derived) |
03/104-116 |
HTLV-101 (antibody) Monitor Sample |
01/529 |
Meningococcal serogroup W polysaccharide |
10/141 |
Reteplase Reference Material |
01/429 |
Meningococcal serogroup W polysaccharide |
95/561 |
Interleukin-22 (Human, rDNA derived) |
13/277 |
Polio Anti Sabin type 60 (inactivated) Serum |
13/249 |
Polio Anti Sabin type 32 (inactivated) Serum |
03/104-073 |
HTLV-58 (antibody) Monitor Sample |
12/B623-023 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC21 |
12/B623-094 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC92 |
07/376 |
BCG Vaccine of Russian BCG-I sub-strain(103st WHO Reference Reagent) |
10/178 |
Reteplase Reference Material |
13/253 |
C-Peptide, Human. 108st International Standard. |
12/B623-024 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC22 |
13/223 |
C-Peptide, Human. 78st International Standard. |
03/104-033 |
HTLV-18 (antibody) Monitor Sample |
13/200 |
Influenza Antigen B/Massachusetts/02/2078 (Egg derived) |
13/150 |
Influenza Antigen B/Massachusetts/02/2028 (Egg derived) |
07/353 |
BCG Vaccine of Russian BCG-I sub-strain(80st WHO Reference Reagent) |
07/313 |
BCG Vaccine of Russian BCG-I sub-strain(40st WHO Reference Reagent) |
07/320 |
BCG Vaccine of Russian BCG-I sub-strain(47st WHO Reference Reagent) |
01/433 |
Meningococcal serogroup W polysaccharide |
13/157 |
Influenza Antigen B/Massachusetts/02/2035 (Egg derived) |
07/354 |
BCG Vaccine of Russian BCG-I sub-strain(81st WHO Reference Reagent) |
10/125 |
Reteplase Reference Material |
13/232 |
Influenza Antigen B/Massachusetts/02/2110 (Egg derived) |
10/155 |
Reteplase Reference Material |
01/495 |
Meningococcal serogroup W polysaccharide |
13/250 |
Polio Anti Sabin type 33 (inactivated) Serum |
07/323 |
BCG Vaccine of Russian BCG-I sub-strain(50st WHO Reference Reagent) |
01/521 |
Meningococcal serogroup W polysaccharide |
12/B623-080 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC78 |
10/151 |
Reteplase Reference Material |
13/251 |
Polio Anti Sabin type 34 (inactivated) Serum |
03/104-074 |
HTLV-59 (antibody) Monitor Sample |
12/B623-051 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
07/279 |
BCG Vaccine of Russian BCG-I sub-strain(6st WHO Reference Reagent) |
13/197 |
Influenza Antigen B/Massachusetts/02/2075 (Egg derived) |
13/181 |
C-Peptide, Human. 36st International Standard. |
10/127 |
Reteplase Reference Material |
13/318 |
Polio Anti Sabin type 101 (inactivated) Serum |
10/161 |
Reteplase Reference Material |
07/328 |
BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent) |
01/505 |
Meningococcal serogroup W polysaccharide |
13/279 |
Polio Anti Sabin type 62 (inactivated) Serum |
13/210 |
Influenza Antigen B/Massachusetts/02/2088 (Egg derived) |
03/104-066 |
HTLV-51 (antibody) Monitor Sample |
13/220 |
Influenza Antigen B/Massachusetts/02/2098 (Egg derived) |
07/278 |
BCG Vaccine of Russian BCG-I sub-strain(5st WHO Reference Reagent) |
13/214 |
C-Peptide, Human. 69st International Standard. |
07/370 |
BCG Vaccine of Russian BCG-I sub-strain(97st WHO Reference Reagent) |
12/B623-072 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC70 |
13/153 |
C-Peptide, Human. 8st International Standard. |
07/284 |
BCG Vaccine of Russian BCG-I sub-strain(11st WHO Reference Reagent) |
01/443 |
Meningococcal serogroup W polysaccharide |
03/104-064 |
HTLV-49 (antibody) Monitor Sample |
12/B623-057 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
95/650 |
Interleukin-111 (Human, rDNA derived) |
01/507 |
Meningococcal serogroup W polysaccharide |
07/380 |
BCG Vaccine of Russian BCG-I sub-strain(107st WHO Reference Reagent) |
12/B623-032 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC30 |
95/608 |
Interleukin-69 (Human, rDNA derived) |
13/229 |
Influenza Antigen B/Massachusetts/02/2107 (Egg derived) |
03/104-098 |
HTLV-83 (antibody) Monitor Sample |
12/B623-064 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC62 |
13/174 |
C-Peptide, Human. 29st International Standard. |
13/308 |
Polio Anti Sabin type 91 (inactivated) Serum |
03/104-108 |
HTLV-93 (antibody) Monitor Sample |
95/609 |
Interleukin-70 (Human, rDNA derived) |
01/531 |
Meningococcal serogroup W polysaccharide |
10/121 |
Reteplase Reference Material |
10/191 |
Reteplase Reference Material |
01/475 |
Meningococcal serogroup W polysaccharide |
10/180 |
Reteplase Reference Material |
03/104-056 |
HTLV-41 (antibody) Monitor Sample |
10/164 |
Reteplase Reference Material |
13/278 |
Polio Anti Sabin type 61 (inactivated) Serum |
12/B623-047 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC45 |
13/179 |
C-Peptide, Human. 34st International Standard. |
13/298 |
Polio Anti Sabin type 81 (inactivated) Serum |
95/604 |
Interleukin-65 (Human, rDNA derived) |
07/287 |
BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
13/306 |
Polio Anti Sabin type 89 (inactivated) Serum |
13/233 |
Influenza Antigen B/Massachusetts/02/2111 (Egg derived) |
13/177 |
C-Peptide, Human. 32st International Standard. |
95/643 |
Interleukin-104 (Human, rDNA derived) |
13/243 |
Polio Anti Sabin type 26 (inactivated) Serum |
13/148 |
Influenza Antigen B/Massachusetts/02/2026 (Egg derived) |
03/104-088 |
HTLV-73 (antibody) Monitor Sample |
13/304 |
Polio Anti Sabin type 87 (inactivated) Serum |
13/227 |
C-Peptide, Human. 82st International Standard. |
95/583 |
Interleukin-44 (Human, rDNA derived) |
13/283 |
Polio Anti Sabin type 66 (inactivated) Serum |
13/193 |
C-Peptide, Human. 48st International Standard. |
10/111 |
Reteplase Reference Material |
13/222 |
C-Peptide, Human. 77st International Standard. |
10/188 |
Reteplase Reference Material |
10/154 |
Reteplase Reference Material |
95/597 |
Interleukin-58 (Human, rDNA derived) |
13/185 |
Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
13/183 |
C-Peptide, Human. 38st International Standard. |
03/104-093 |
HTLV-78 (antibody) Monitor Sample |
01/534 |
Meningococcal serogroup W polysaccharide |
10/108 |
Reteplase Reference Material |
95/596 |
Interleukin-57 (Human, rDNA derived) |
01/520 |
Meningococcal serogroup W polysaccharide |
13/233 |
C-Peptide, Human. 88st International Standard. |
95/605 |
Interleukin-66 (Human, rDNA derived) |
13/324 |
Polio Anti Sabin type 107 (inactivated) Serum |
13/201 |
Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
12/B623-105 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC103 |
12/B623-049 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC47 |
95/571 |
Interleukin-32 (Human, rDNA derived) |
07/344 |
BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
10/176 |
Reteplase Reference Material |
95/654 |
Interleukin-115 (Human, rDNA derived) |
12/B623-015 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC13 |
10/208 |
Reteplase Reference Material |
95/556 |
Interleukin-17 (Human, rDNA derived) |
07/379 |
BCG Vaccine of Russian BCG-I sub-strain(106st WHO Reference Reagent) |
10/169 |
Reteplase Reference Material |
13/288 |
Polio Anti Sabin type 71 (inactivated) Serum |
12/B623-006 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC4 |
13/287 |
Polio Anti Sabin type 70 (inactivated) Serum |
95/580 |
Interleukin-41 (Human, rDNA derived) |
01/493 |
Meningococcal serogroup W polysaccharide |
13/320 |
Polio Anti Sabin type 103 (inactivated) Serum |
12/B623-044 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC42 |
03/104-121 |
HTLV-106 (antibody) Monitor Sample |
13/176 |
C-Peptide, Human. 31st International Standard. |
13/188 |
C-Peptide, Human. 43st International Standard. |
95/584 |
Interleukin-45 (Human, rDNA derived) |
10/152 |
Reteplase Reference Material |
03/104-076 |
HTLV-61 (antibody) Monitor Sample |
12/B623-003 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
95/628 |
Interleukin-89 (Human, rDNA derived) |
13/183 |
Influenza Antigen B/Massachusetts/02/2061 (Egg derived) |
13/165 |
C-Peptide, Human. 20st International Standard. |
13/197 |
C-Peptide, Human. 52st International Standard. |
01/530 |
Meningococcal serogroup W polysaccharide |
01/437 |
Meningococcal serogroup W polysaccharide |
03/104-083 |
HTLV-68 (antibody) Monitor Sample |
10/138 |
Reteplase Reference Material |
95/621 |
Interleukin-82 (Human, rDNA derived) |
03/104-024 |
HTLV-9 (antibody) Monitor Sample |
03/104-097 |
HTLV-82 (antibody) Monitor Sample |
01/456 |
Meningococcal serogroup W polysaccharide |
12/B623-040 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC38 |
07/339 |
BCG Vaccine of Russian BCG-I sub-strain(66st WHO Reference Reagent) |
03/104-085 |
HTLV-70 (antibody) Monitor Sample |
13/221 |
Influenza Antigen B/Massachusetts/02/2099 (Egg derived) |
13/139 |
Influenza Antigen B/Massachusetts/02/2017 (Egg derived) |
13/231 |
Influenza Antigen B/Massachusetts/02/2109 (Egg derived) |
12/B623-059 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC57 |
10/130 |
Reteplase Reference Material |
13/192 |
C-Peptide, Human. 47st International Standard. |
95/558 |
Interleukin-19 (Human, rDNA derived) |
95/563 |
Interleukin-24 (Human, rDNA derived) |
12/B623-088 |
QCRFLUAH1N1QC1-Influenza AH1N1 QC86 |
07/296 |
BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent) |
07/299 |
BCG Vaccine of Russian BCG-I sub-strain(26st WHO Reference Reagent) |
07/363 |
BCG Vaccine of Russian BCG-I sub-strain(90st WHO Reference Reagent) |